{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:33:16Z","timestamp":1787563996802,"version":"build-2736575974"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK128991"],"award-info":[{"award-number":["DK128991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["3-SRA-2021\u20131033-S-B"],"award-info":[{"award-number":["3-SRA-2021\u20131033-S-B"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","award":["DK108736"],"award-info":[{"award-number":["DK108736"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","award":["DK122638"],"award-info":[{"award-number":["DK122638"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","award":["DK126413"],"award-info":[{"award-number":["DK126413"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.actbio.2021.05.039","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T11:42:05Z","timestamp":1622893325000},"page":"87-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9500-0887","authenticated-orcid":false,"given":"Magdalena M.","family":"Samojlik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0573-0646","authenticated-orcid":false,"given":"Cherie L.","family":"Stabler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J. Exp. Med."},{"issue":"9911","key":"10.1016\/j.actbio.2021.05.039_bib0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2021.05.039_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2015.08.012","article-title":"T cells in Type 1 Diabetes: Instructors, regulators and effectors: a comprehensive review","volume":"66","author":"Gomez-Tourino","year":"2016","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0004","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1172\/JCI78089","article-title":"T cells in the control of organ-specific autoimmunity","volume":"125","author":"Bluestone","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2213-8587(19)30412-7","article-title":"Type 1 diabetes-early life origins and changing epidemiology","volume":"8","author":"Norris","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4093\/dmj.2019.0121","article-title":"Continuous glucose monitoring sensors for diabetes management: a review of technologies and applications","volume":"43","author":"Cappon","year":"2019","journal-title":"Diabetes Metab. J."},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0007","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.2337\/db11-0654","article-title":"Artificial pancreas: past, present, future","volume":"60","author":"Cobelli","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.actbio.2021.05.039_bib0008","first-page":"211","article-title":"Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges","volume":"7","author":"Bruni","year":"2014","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrendo.2016.178","article-title":"Clinical pancreatic islet transplantation","volume":"13","author":"Shapiro","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri1332","article-title":"Clinical islet transplantation: advances and immunological challenges","volume":"4","author":"Ricordi","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0011","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/db10-0895","article-title":"Markedly decreased blood perfusion of pancreatic islets transplanted intraportally into the liver: disruption of islet integrity necessary for islet revascularization","volume":"61","author":"Henriksn\u00e4s","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.actbio.2021.05.039_bib0012","series-title":"10th Annual Report","year":"2017"},{"issue":"13","key":"10.1016\/j.actbio.2021.05.039_bib0013","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0014","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/diabetes.50.4.710","article-title":"Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol","volume":"50","author":"Ryan","year":"2001","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0016","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in Type 1 Diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0017","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2337\/dci19-0080","article-title":"Improving clinical islet transplantation outcomes","volume":"43","author":"Roep","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0018","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.actbio.2021.05.039_bib0019","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2337\/db09-0476","article-title":"Current advances and travails in islet transplantation","volume":"58","author":"Harlan","year":"2009","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.actbio.2021.05.039_bib0020","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/diabetes.48.10.1907","article-title":"Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?","volume":"48","author":"Bennet","year":"1999","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0021","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/ajt.12558","article-title":"Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation","volume":"14","author":"Naziruddin","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.actbio.2021.05.039_bib0022","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1056\/NEJMc070201","article-title":"Visualization of early engraftment in clinical islet transplantation by positron-emission tomography","volume":"356","author":"Eich","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0023","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/TP.0b013e31816b22f3","article-title":"Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation","volume":"85","author":"Tjernberg","year":"2008","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0024","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/MOT.0b013e32834c2393","article-title":"Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment","volume":"16","author":"Nilsson","year":"2011","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"119","key":"10.1016\/j.actbio.2021.05.039_bib0025","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ki.2010.416","article-title":"T-cell alloimmunity and chronic allograft dysfunction","volume":"78","author":"Safinia","year":"2010","journal-title":"Kidney Int. Suppl."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0026","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOT.0b013e328309ee31","article-title":"Pathways of major histocompatibility complex allorecognition","volume":"13","author":"Afzali","year":"2008","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.actbio.2021.05.039_bib0027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1749-6632.1999.tb08508.x","article-title":"Antigen presentation pathways for immunity to islet transplants. Relevance to immunoisolation","volume":"875","author":"Gill","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0028","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0167-5699(98)01394-2","article-title":"Direct and indirect recognition: the role of MHC antigens in graft rejection","volume":"20","author":"Gould","year":"1999","journal-title":"Immunol. Today"},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0029","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-6143.2001.10201.x","article-title":"Allorecognition","volume":"1","author":"Rogers","year":"2001","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.actbio.2021.05.039_bib0030","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3389\/fimmu.2018.02548","article-title":"T cell allorecognition pathways in solid organ transplantation","volume":"9","author":"Siu","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0031","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1600-6143.2011.03437.x","article-title":"Coexpression of donor peptide\/recipient MHC complex and intact donor MHC: evidence for a link between the direct and indirect pathways","volume":"11","author":"Brown","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0032","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4049\/jimmunol.166.2.973","article-title":"Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question","volume":"166","author":"Suchin","year":"2001","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0033","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-200108150-00020","article-title":"The role of the allograft in the induction of donor-specific T cell hyporesponsiveness","volume":"72","author":"Baker","year":"2001","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0034","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.tp.0000257960.07783.e3","article-title":"Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity","volume":"83","author":"Taylor","year":"2007","journal-title":"Transplantation"},{"issue":"6684","key":"10.1016\/j.actbio.2021.05.039_bib0035","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic-T-cell responses is mediated by CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0036","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1600-6143.2009.02578.x","article-title":"Preferential priming of alloreactive T cells with indirect reactivity","volume":"9","author":"Brennan","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0037","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0167-5699(94)90023-X","article-title":"Indirect presentation of MHC antigens in transplantation","volume":"15","author":"Shoskes","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.actbio.2021.05.039_bib0038","first-page":"D476","article-title":"Direct and indirect antigen recognition: the pathways to allograft immune rejection","volume":"4","author":"Benichou","year":"1999","journal-title":"Front. Biosci."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0039","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1073\/pnas.90.8.3373","article-title":"The role of \"indirect\" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice","volume":"90","author":"Auchincloss","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"343","key":"10.1016\/j.actbio.2021.05.039_bib0040","article-title":"T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of Type 1 Diabetes","volume":"8","author":"Burrack","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0041","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1096\/fj.08-107441","article-title":"Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation","volume":"22","author":"Brown","year":"2008","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0042","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI84577","article-title":"Donor dendritic cell-derived exosomes promote allograft-targeting immune response","volume":"126","author":"Liu","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0043","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.4049\/jimmunol.1300458","article-title":"Copresentation of intact and processed MHC alloantigen by recipient dendritic cells enables delivery of linked help to alloreactive CD8 T cells by indirect-pathway CD4 T cells","volume":"190","author":"Sivaganesh","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0044","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MOT.0000000000000263","article-title":"Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms","volume":"21","author":"Lin","year":"2016","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0045","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1172\/JCI10467","article-title":"CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II","volume":"106","author":"Pietra","year":"2000","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0046","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cellimm.2014.11.007","article-title":"Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4(+) T-cell mediated rejection","volume":"293","author":"Plenter","year":"2015","journal-title":"Cell. Immunol."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0047","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1172\/JCI74370","article-title":"Non-self recognition by monocytes initiates allograft rejection","volume":"124","author":"Oberbarnscheidt","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0048","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41423-019-0216-2","article-title":"The innate immune response to allotransplants: mechanisms and therapeutic potentials","volume":"16","author":"Ochando","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.actbio.2021.05.039_bib0049","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3389\/fimmu.2020.00918","article-title":"Innate allorecognition and memory in transplantation","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/MOT.0000000000000708","article-title":"Linking innate immunity and chronic antibody-mediated allograft rejection","volume":"24","author":"Gill","year":"2019","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0051","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1600-6143.2004.00520.x","article-title":"Alloantibody production is regulated by CD4+ T cells' alloreactive pathway, rather than precursor frequency or Th1\/Th2 differentiation","volume":"4","author":"Sauv\u00e9","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0052","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T cell responses: naive to memory and everything in between","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv. Physiol. Educ."},{"issue":"Suppl","key":"10.1016\/j.actbio.2021.05.039_bib0053","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0092-8674(02)00704-3","article-title":"Pathways of apoptosis in lymphocyte development, homeostasis and disease","volume":"109","author":"Rathmell","year":"2002","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0054","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.1700856","article-title":"Simultaneous recognition of allogeneic mhc and cognate autoantigen by autoreactive t cells in transplant rejection","volume":"200","author":"Burrack","year":"2018","journal-title":"J. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.actbio.2021.05.039_bib0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/diab.38.1.S85","article-title":"Recurrence of disease in pancreas transplants","volume":"38","author":"Sutherland","year":"1989","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0056","first-page":"132","article-title":"Recurrent diabetes mellitus in the pancreas iso- and allograft. a light and electron microscopic and immunohistochemical analysis of four cases","volume":"53","author":"Sibley","year":"1985","journal-title":"Lab. Investig."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0057","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/icb.2010.150","article-title":"The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection","volume":"89","author":"Gras","year":"2011","journal-title":"Immunol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0058","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.coi.2008.07.006","article-title":"T-cells behaving badly: structural insights into alloreactivity and autoimmunity","volume":"20","author":"Ely","year":"2008","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0059","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrneph.2016.9","article-title":"Memory T cells in organ transplantation: progress and challenges","volume":"12","author":"Espinosa","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","article-title":"Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion","volume":"5","author":"Pearl","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0061","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.4049\/jimmunol.176.8.4632","article-title":"Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it","volume":"176","author":"Neujahr","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0062","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/ajt.12574","article-title":"The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation","volume":"14","author":"Xu","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0063","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ajt.13613","article-title":"CD57(+) CD4 T cells underlie belatacept-resistant allograft rejection","volume":"16","author":"Espinosa","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0064","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ajt.13426","article-title":"Risk factors for Type 1 Diabetes recurrence in immunosuppressed recipients of simultaneous pancreas-kidney transplants","volume":"16","author":"Vendrame","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2337\/db09-0498","article-title":"Recurrence of Type 1 Diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells","volume":"59","author":"Vendrame","year":"2010","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0066","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2008.03.459","article-title":"Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation","volume":"128","author":"Laughlin","year":"2008","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0067","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1586\/eci.11.19","article-title":"Development of diabetes mellitus in living pancreas donors and recipients","volume":"7","author":"Gruessner","year":"2011","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0068","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2337\/diabetes.50.11.2464","article-title":"Autoantibody response to islet transplantation in Type 1 Diabetes","volume":"50","author":"Bosi","year":"2001","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.actbio.2021.05.039_bib0069","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/diab.38.1.S82","article-title":"Islet cell autoimmunity in Type I diabetic patients after HLA-mismatched pancreas transplantation","volume":"38","author":"Bosi","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.actbio.2021.05.039_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580483","article-title":"Diverse routes of allograft tolerance disruption by memory T cells","volume":"11","author":"Gill","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0071","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11892-013-0414-8","article-title":"Biologic agents in islet transplantation","volume":"13","author":"Gala-Lopez","year":"2013","journal-title":"Curr. Diabetes Rep."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0072","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/snep.2001.24945","article-title":"Acute and chronic rejection","volume":"21","author":"Tejani","year":"2001","journal-title":"Semin. Nephrol."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0073","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.transproceed.2015.08.009","article-title":"Efficacy and safety of basiliximab versus daclizumab in kidney transplantation: a meta-analysis","volume":"47","author":"Sun","year":"2015","journal-title":"Transplant. Proc."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0074","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/07853890.2016.1257862","article-title":"Anti-interleukin-2 receptor antibodies for the prevention of rejection in liver transplant recipients: a systematic review and meta-analysis","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann. Med."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0075","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.4049\/jimmunol.165.6.3031","article-title":"The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells","volume":"165","author":"Dai","year":"2000","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.actbio.2021.05.039_bib0076","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/db09-0557","article-title":"Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice","volume":"58","author":"Parker","year":"2009","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0077","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.actbio.2021.05.039_bib0078","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/TP.0b013e31819025e5","article-title":"Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes","volume":"86","author":"Froud","year":"2008","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0079","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/eji.201545708","article-title":"Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes","volume":"46","author":"Tooley","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0080","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/14712591003598843","article-title":"Teplizumab therapy for type 1 diabetes","volume":"10","author":"Masharani","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0081","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/er.2018-00154","article-title":"Pancreatic islet transplantation in humans: recent progress and future directions","volume":"40","author":"Rickels","year":"2018","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0082","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","article-title":"Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in Type 1 Diabetes","volume":"12","author":"Bellin","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0083","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00592-011-0315-8","article-title":"Deterioration of glycemic control after corticosteroid administration in islet autotransplant recipients: a cautionary tale","volume":"51","author":"Ngo","year":"2014","journal-title":"Acta Diabetol."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0084","first-page":"3105","article-title":"Adverse effects associated with the use of FK 506","volume":"23","author":"Fung","year":"1991","journal-title":"Transplant. Proc."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0085","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0086","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1681\/ASN.2010040351","article-title":"The evolving role of mTOR inhibition in transplantation tolerance","volume":"22","author":"McMahon","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0087","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1432-2277.2008.00743.x","article-title":"Rapamycin in islet transplantation: friend or foe?","volume":"22","author":"Berney","year":"2009","journal-title":"Transpl. Int."},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0088","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00125-007-0670-8","article-title":"Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugs","volume":"50","author":"Cross","year":"2007","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0089","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.tp.0000255679.81792.dd","article-title":"In vivo and in vitro effect of sirolimus on insulin secretion","volume":"83","author":"Marcelli-Tourvieille","year":"2007","journal-title":"Transplantation"},{"issue":"2-3","key":"10.1016\/j.actbio.2021.05.039_bib0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0162-3109(00)00190-9","article-title":"The use of mycophenolate mofetil in transplant recipients","volume":"47","author":"Mele","year":"2000","journal-title":"Immunopharmacology"},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0091","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2012.04341.x","article-title":"Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy","volume":"13","author":"Lowe","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.actbio.2021.05.039_bib0092","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/TP.0b013e3181fe1377","article-title":"Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade","volume":"90","author":"Posselt","year":"2010","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0093","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/MOT.0b013e328332bd4a","article-title":"Memory T-cell-specific therapeutics in organ transplantation","volume":"14","author":"Page","year":"2009","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"12","key":"10.1016\/j.actbio.2021.05.039_bib0094","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1172\/JCI43895","article-title":"LFA-1-specific therapy prolongs allograft survival in rhesus macaques","volume":"120","author":"Badell","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0095","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1600-6143.2010.03073.x","article-title":"Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab","volume":"10","author":"Posselt","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0096","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nm.1993","article-title":"Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates","volume":"15","author":"Weaver","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2021.05.039_bib0097","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1089\/dia.2020.0305","article-title":"Comparing beta cell preservation across clinical trials in recent-onset Type 1 Diabetes","volume":"22","author":"Jacobsen","year":"2020","journal-title":"Diabetes Technol. Ther."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0098","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(13)70111-6","article-title":"Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial","volume":"1","author":"Rigby","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.actbio.2021.05.039_bib0099","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41409-020-01049-0","article-title":"Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease","volume":"56","author":"Kekre","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbmt.2018.11.013","article-title":"Safety and effectiveness of vedolizumab in patients with steroid-refractory gastrointestinal acute graft-versus-host disease: a retrospective record review","volume":"25","author":"Fl\u00f8isand","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0101","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1111\/j.1600-6143.2009.02798.x","article-title":"Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression","volume":"9","author":"Pinsky","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.actbio.2021.05.039_bib0102","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/j.1600-6143.2007.01966.x","article-title":"A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients","volume":"7","author":"Takemoto","year":"2007","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0103","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CNQ.0000000000000117","article-title":"Immunosuppression in Solid-organ transplantation: essentials and practical tips","volume":"39","author":"Jasiak","year":"2016","journal-title":"Crit. Care Nurs. Q."},{"key":"10.1016\/j.actbio.2021.05.039_bib0104","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12938-015-0021-9","article-title":"Experimental evaluation and computational modeling of the effects of encapsulation on the time-profile of glucose-stimulated insulin release of pancreatic islets","volume":"14","author":"Buchwald","year":"2015","journal-title":"Biomed. Eng. Online"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/bit.26442","article-title":"Glucose-stimulated insulin release: Parallel perifusion studies of free and hydrogel encapsulated human pancreatic islets","volume":"115","author":"Buchwald","year":"2018","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0106","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/jbm.a.32134","article-title":"Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function","volume":"90","author":"Weber","year":"2009","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.actbio.2021.05.039_bib0107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2741\/4195","article-title":"Membranes to achieve immunoprotection of transplanted islets","volume":"19","author":"Schweicher","year":"2014","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"1-2","key":"10.1016\/j.actbio.2021.05.039_bib0108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00054-5","article-title":"Immunocompatibility and biocompatibility of cell delivery systems","volume":"42","author":"R\u00edhov\u00e1","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0109","doi-asserted-by":"crossref","first-page":"23679","DOI":"10.1038\/srep23679","article-title":"Silicon nanopore membrane (SNM) for islet encapsulation and immunoisolation under convective transport","volume":"6","author":"Song","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/ten.teb.2007.0332","article-title":"Cell encapsulation in biodegradable hydrogels for tissue engineering applications","volume":"14","author":"Nicodemus","year":"2008","journal-title":"Tissue Eng. Part B Rev."},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0111","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41551-018-0275-1","article-title":"Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques","volume":"2","author":"Bochenek","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.actbio.2021.05.039_bib0112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-319-18603-0_12","article-title":"Cell surface engineering for regulation of immune reactions in cell therapy","volume":"865","author":"Teramura","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.actbio.2021.05.039_bib0113","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3727\/096368908786991515","article-title":"The choice of anatomical site for islet transplantation","volume":"17","author":"Van Der Windt","year":"2008","journal-title":"Cell. Transplant."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0114","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrd.2016.232","article-title":"Advances in islet encapsulation technologies","volume":"16","author":"Desai","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41578-019-0112-5","article-title":"Engineering immunomodulatory biomaterials for type 1 diabetes","volume":"4","author":"Stabler","year":"2019","journal-title":"Nat. Rev. Mater."},{"issue":"19-20","key":"10.1016\/j.actbio.2021.05.039_bib0116","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1089\/ten.tea.2016.0477","article-title":"Hyaluronic acid\/collagen hydrogel as an alternative to alginate for long-term immunoprotected islet transplantation","volume":"23","author":"Harrington","year":"2017","journal-title":"Tissue Eng. Part A"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0117","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jbm.a.10522","article-title":"In vivo biocompatibility evaluation of cellulose macrocapsules for islet immunoisolation: Implications of low molecular weight cut-off","volume":"66","author":"Risbud","year":"2003","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0118","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1163\/156856201753395770","article-title":"Islet immunoisolation: experience with biopolymers","volume":"12","author":"Risbud","year":"2001","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0119","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bbrc.2010.02.089","article-title":"The cytoprotection of chitosan based hydrogels in xenogeneic islet transplantation: An in vivo study in streptozotocin-induced diabetic mouse","volume":"393","author":"Yang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0120","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.2337\/diabetes.50.8.1698","article-title":"Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane","volume":"50","author":"Duvivier-Kali","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.actbio.2021.05.039_bib0121","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2013.07.018","article-title":"Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution","volume":"67-68","author":"Scharp","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0122","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s00125-013-2921-1","article-title":"Islet encapsulation: advances and obstacles","volume":"56","author":"Weir","year":"2013","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.actbio.2021.05.039_bib0123","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/TP.0b013e3181f6e267","article-title":"Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression","volume":"90","author":"Dufrane","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0124","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.progpolymsci.2011.06.003","article-title":"Alginate: properties and biomedical applications","volume":"37","author":"Lee","year":"2012","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.actbio.2021.05.039_bib0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmbbm.2014.05.020","article-title":"Factors influencing the mechanical stability of alginate beads applicable for immunoisolation of mammalian cells","volume":"37","author":"Bhujbal","year":"2014","journal-title":"J. Mech. Behav. Biomed. Mater."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0126","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00007890-199211000-00001","article-title":"Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets","volume":"54","author":"Soon-Shiong","year":"1992","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0127","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00007890-199904270-00004","article-title":"Xenotransplantation of cells using biodegradable microcapsules","volume":"67","author":"Lanza","year":"1999","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00569928","article-title":"Islet microencapsulation: a review","volume":"30","author":"Clayton","year":"1993","journal-title":"Acta Diabetol."},{"issue":"46","key":"10.1016\/j.actbio.2021.05.039_bib0129","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1039\/C4TB01241K","article-title":"Covalent layer-by-layer assembly of hyperbranched polymers on alginate microcapsulesto impart stability and permselectivity","volume":"2","author":"Gatt\u00e1s-Asfura","year":"2014","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0130","doi-asserted-by":"crossref","DOI":"10.1002\/mame.201800679","article-title":"Characterization of polyethylene glycol-reinforced alginate microcapsules for mechanically stable cell immunoisolation","volume":"304","author":"Verheyen","year":"2019","journal-title":"Macromol. Mater. Eng."},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0131","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jbm.820260711","article-title":"Agarose for a bioartificial pancreas","volume":"26","author":"Iwata","year":"1992","journal-title":"J. Biomed. Mater. Res."},{"issue":"9","key":"10.1016\/j.actbio.2021.05.039_bib0132","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jbm.820280905","article-title":"Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas","volume":"28","author":"Iwata","year":"1994","journal-title":"J. Biomed. Mater. Res."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0133","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/01.TP.0000053749.36365.7E","article-title":"Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression","volume":"75","author":"Kobayashi","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.actbio.2021.05.039_bib0134","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fbioe.2019.00134","article-title":"Polymeric approaches to reduce tissue responses against devices applied for islet-cell encapsulation","volume":"7","author":"Hu","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I","article-title":"Stability of hydrogels used in cell encapsulation: an in vitro comparison of alginate and agarose","volume":"50","author":"Shoichet","year":"1996","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0136","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1021\/acs.biomac.7b01715","article-title":"Diels-alder click-cross-linked hydrogels with increased reactivity enable 3D cell encapsulation","volume":"19","author":"Smith","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2021.05.039_bib0137","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.actbio.2017.12.007","article-title":"The impact of functional groups of poly(ethylene glycol) macromers on the physical properties of photo-polymerized hydrogels and the local inflammatory response in the host","volume":"67","author":"Day","year":"2018","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2005.10.005","article-title":"PEG-based hydrogels as an in vitro encapsulation platform for testing controlled \u03b2-cell microenvironments","volume":"2","author":"Weber","year":"2006","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0139","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/ajt.14547","article-title":"Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol","volume":"18","author":"Manzoli","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"19","key":"10.1016\/j.actbio.2021.05.039_bib0140","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.biomaterials.2013.03.012","article-title":"Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes","volume":"34","author":"Phelps","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.05.039_bib0141","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biomaterials.2018.04.047","article-title":"Design of a vascularized synthetic poly(ethylene glycol) macroencapsulation device for islet transplantation","volume":"172","author":"Weaver","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.05.039_bib0142","article-title":"RGD-modified injectable hydrogel maintains islet beta-cell survival and function","volume":"18","author":"Lan","year":"2020","journal-title":"J. Appl. Biomater. Funct. Mater."},{"issue":"16","key":"10.1016\/j.actbio.2021.05.039_bib0143","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1073\/pnas.1014026108","article-title":"Cell-cell communication mimicry with poly(ethylene glycol) hydrogels for enhancing beta-cell function","volume":"108","author":"Lin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0144","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/ajt.15168","article-title":"Synthetic poly(ethylene glycol)-based microfluidic islet encapsulation reduces graft volume for delivery to highly vascularized and retrievable transplant site","volume":"19","author":"Weaver","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/096368979900800310","article-title":"In Vitro and in Vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes","volume":"8","author":"Cruise","year":"1999","journal-title":"Cell. Transplant."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0146","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.stemcr.2019.11.004","article-title":"Conformal coating of stem cell-derived islets for \u03b2 cell replacement in Type 1 Diabetes","volume":"14","author":"Stock","year":"2020","journal-title":"Stem Cell Rep."},{"issue":"29","key":"10.1016\/j.actbio.2021.05.039_bib0147","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1073\/pnas.1402216111","article-title":"Device design and materials optimization of conformal coating for islets of Langerhans","volume":"111","author":"Tomei","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.actbio.2021.05.039_bib0148","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.actbio.2016.11.060","article-title":"The impact of cell surface PEGylation and short-course immunotherapy on islet graft survival in an allogeneic murine model","volume":"49","author":"Giraldo","year":"2017","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0149","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1089\/ten.2006.0009","article-title":"Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication","volume":"13","author":"Lee","year":"2007","journal-title":"Tissue Eng."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/ten.2006.12.615","article-title":"A new strategy toward improving immunoprotection in cell therapy for diabetes mellitus: long-functioning PEGylated islets in vivo","volume":"12","author":"Lee","year":"2006","journal-title":"Tissue Eng."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0151","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/ajt.15643","article-title":"Transplantation of PEGylated islets enhances therapeutic efficacy in a diabetic nonhuman primate model","volume":"20","author":"Stabler","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.actbio.2021.05.039_bib0152","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1749-6632.1997.tb52208.x","article-title":"Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets","volume":"831","author":"Hill","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0153","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2005.10.023","article-title":"A combination therapy of PEGylation and immunosuppressive agent for successful islet transplantation","volume":"110","author":"Lee","year":"2006","journal-title":"J. Control Release"},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0154","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.biomaterials.2006.12.015","article-title":"Functional and histological evaluation of transplanted pancreatic islets immunoprotected by PEGylation and cyclosporine for 1 year","volume":"28","author":"Yun Lee","year":"2007","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0155","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1021\/cr2000916","article-title":"Biocompatible and bioactive surface modifications for prolonged in vivo efficacy","volume":"112","author":"Meyers","year":"2012","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0156","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/adhm.201300573","article-title":"Long-term survival of allograft murine islets coated via covalently stabilized polymers","volume":"3","author":"Rengifo","year":"2014","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0157","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/acsbiomaterials.9b01033","article-title":"Promoting dendrimer self-assembly enhances covalent layer-by-layer encapsulation of pancreatic islets","volume":"6","author":"Gatt\u00e1s-Asfura","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"20","key":"10.1016\/j.actbio.2021.05.039_bib0158","doi-asserted-by":"crossref","first-page":"9964","DOI":"10.1021\/am401981g","article-title":"Bioorthogonal layer-by-layer encapsulation of pancreatic islets via hyperbranched polymers","volume":"5","author":"Gatt\u00e1s-Asfura","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0159","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/nl080694q","article-title":"Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation","volume":"8","author":"Wilson","year":"2008","journal-title":"Nano Lett."},{"issue":"32","key":"10.1016\/j.actbio.2021.05.039_bib0160","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1016\/j.biomaterials.2007.07.050","article-title":"Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane","volume":"28","author":"Teramura","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.05.039_bib0161","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120182","article-title":"In vitro platform establishes antigen-specific CD8(+) T cell cytotoxicity to encapsulated cells via indirect antigen recognition","volume":"256","author":"Li","year":"2020","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0162","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/diab.46.11.1907","article-title":"Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts","volume":"46","author":"Jaeger","year":"1997","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0163","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00007890-200001150-00018","article-title":"Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation","volume":"69","author":"Thivolet","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0164","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/xen.12086","article-title":"Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice","volume":"21","author":"Safley","year":"2014","journal-title":"Xenotransplantation"},{"issue":"12","key":"10.1016\/j.actbio.2021.05.039_bib0165","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1600-6143.2004.00628.x","article-title":"Survival of microencapsulated adult pig islets in mice in spite of an antibody response","volume":"4","author":"Duvivier-Kali","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.actbio.2021.05.039_bib0166","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/01.TP.0000142094.63083.FB","article-title":"In vivo recognition by the host adaptive immune system of microencapsulated xenogeneic cells","volume":"78","author":"Jones","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0167","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s001090050339","article-title":"Analysis of the cellular reaction towards microencapsulated xenogeneic islets after intraperitoneal transplantation","volume":"77","author":"Siebers","year":"1999","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0168","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","article-title":"Foreign body reaction to biomaterials","volume":"20","author":"Anderson","year":"2008","journal-title":"Semin. Immunol."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0169","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nmat4290","article-title":"Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates","volume":"14","author":"Veiseh","year":"2015","journal-title":"Nat. Mater."},{"issue":"22","key":"10.1016\/j.actbio.2021.05.039_bib0170","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1021\/ja042898o","article-title":"Interpretation of protein adsorption: surface-induced conformational changes","volume":"127","author":"Roach","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.039_bib0171","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1039\/C5BM00613A","article-title":"Simultaneous characterization of protein-material and cell-protein interactions using dynamic QCM-D analysis on SAM surfaces","volume":"4","author":"Kushiro","year":"2016","journal-title":"Biomater. Sci."},{"issue":"31","key":"10.1016\/j.actbio.2021.05.039_bib0172","doi-asserted-by":"crossref","first-page":"27615","DOI":"10.1021\/acsami.9b09900","article-title":"Biomaterial surface hydrophobicity-mediated serum protein adsorption and immune responses","volume":"11","author":"Visalakshan","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0173","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/ajt.14642","article-title":"Transplantation of macroencapsulated human islets within the bioartificial pancreas \u03b2Air to patients with type 1 diabetes mellitus","volume":"18","author":"Carlsson","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0174","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/TP.0000000000002217","article-title":"Report of the key opinion leaders meeting on stem cell-derived beta cells","volume":"102","author":"Odorico","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/02652049109071490","article-title":"The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules","volume":"8","author":"Clayton","year":"1991","journal-title":"J. Microencapsul."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0176","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s001250050673","article-title":"Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets","volume":"40","author":"De Vos","year":"1997","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0177","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nbt.3462","article-title":"Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates","volume":"34","author":"Vegas","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2021.05.039_bib0178","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119640","article-title":"Developing mechanically robust, triazole-zwitterionic hydrogels to mitigate foreign body response (FBR) for islet encapsulation","volume":"230","author":"Liu","year":"2020","journal-title":"Biomaterials"},{"issue":"22","key":"10.1016\/j.actbio.2021.05.039_bib0179","doi-asserted-by":"crossref","first-page":"eaba0754","DOI":"10.1126\/sciadv.aba0754","article-title":"De novo design of functional zwitterionic biomimetic material for immunomodulation","volume":"6","author":"Li","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MAT.0b013e3181d7b8e3","article-title":"Biocompatibility investigation of polyethylene glycol and alginate-poly-l-lysine for islet encapsulation","volume":"56","author":"Liu","year":"2010","journal-title":"ASAIO J."},{"issue":"15","key":"10.1016\/j.actbio.2021.05.039_bib0181","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1016\/j.biomaterials.2012.02.034","article-title":"Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine","volume":"33","author":"Brown","year":"2012","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0182","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801451","article-title":"Macrophage and fibroblast interactions in biomaterial-mediated fibrosis","volume":"8","author":"Witherel","year":"2019","journal-title":"Adv. Healthc. Mater."},{"issue":"25","key":"10.1016\/j.actbio.2021.05.039_bib0183","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1016\/j.biomaterials.2014.04.115","article-title":"Macrophage polarization in response to ECM coated polypropylene mesh","volume":"35","author":"Wolf","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.05.039_bib0184","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.actbio.2019.05.038","article-title":"Role of dendritic cells in the host response to biomaterials and their signaling pathways","volume":"94","author":"Zhu","year":"2019","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s40472-015-0067-4","article-title":"The impact of regulated cell death pathways on alloimmune responses and graft injury","volume":"2","author":"H\u00e9bert","year":"2015","journal-title":"Curr. Transplant. Rep."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0186","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1067\/msy.1998.91482","article-title":"Living unrelated renal donation: the University of Wisconsin experience","volume":"124","author":"D'Alessandro","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.actbio.2021.05.039_bib0187","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3389\/fimmu.2020.01227","article-title":"The human immune response to cadaveric and living donor liver allografts","volume":"11","author":"Hann","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.actbio.2021.05.039_bib0188","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10495-017-1413-z","article-title":"The immune response to secondary necrotic cells","volume":"22","author":"Sachet","year":"2017","journal-title":"Apoptosis"},{"issue":"2-3","key":"10.1016\/j.actbio.2021.05.039_bib0189","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaut.2007.02.005","article-title":"Clearance deficiency and systemic lupus erythematosus (SLE)","volume":"28","author":"Gaipl","year":"2007","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.actbio.2021.05.039_bib0190","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/eji.201948501","article-title":"Cross-presentation of dead-cell-associated antigens by DNGR-1(+) dendritic cells contributes to chronic allograft rejection in mice","volume":"50","author":"Balam","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actbio.2021.05.039_bib0191","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/352315","article-title":"Revascularization of transplanted pancreatic islets and role of the transplantation site","volume":"2013","author":"Pepper","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0192","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.copbio.2013.05.004","article-title":"Engineering a local microenvironment for pancreatic islet replacement","volume":"24","author":"Coronel","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0193","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568010053622830","article-title":"Role of inflammatory mediators in angiogenesis","volume":"4","author":"Naldini","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"issue":"24","key":"10.1016\/j.actbio.2021.05.039_bib0194","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.2174\/138161206777947461","article-title":"Cytokines and chemokines as regulators of angiogenesis in health and disease","volume":"12","author":"Benelli","year":"2006","journal-title":"Curr. Pharm. Des."},{"issue":"526","key":"10.1016\/j.actbio.2021.05.039_bib0195","doi-asserted-by":"crossref","first-page":"eaan5907","DOI":"10.1126\/scitranslmed.aan5907","article-title":"Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization","volume":"12","author":"Forbes","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actbio.2021.05.039_bib0196","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120324","article-title":"Methacrylic acid copolymer coating of polypropylene mesh chamber improves subcutaneous islet engraftment","volume":"259","author":"Coindre","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.05.039_bib0197","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biomaterials.2019.01.035","article-title":"Biofabrication of a vascularized islet organ for type 1 diabetes","volume":"199","author":"Citro","year":"2019","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0198","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11892-018-1028-y","article-title":"Transplantation of macroencapsulated insulin-producing cells","volume":"18","author":"Hwa","year":"2018","journal-title":"Curr. Diabetes Rep."},{"issue":"13","key":"10.1016\/j.actbio.2021.05.039_bib0199","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1055\/s-0030-1267916","article-title":"A novel device for islet transplantation providing immune protection and oxygen supply","volume":"42","author":"Ludwig","year":"2010","journal-title":"Horm. Metab. Res."},{"issue":"7","key":"10.1016\/j.actbio.2021.05.039_bib0200","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3727\/096368912X657486","article-title":"The TheraCyte\u2122 device protects against islet allograft rejection in immunized hosts","volume":"22","author":"Kumagai-Braesch","year":"2013","journal-title":"Cell. Transplant."},{"key":"10.1016\/j.actbio.2021.05.039_bib0201","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.actbio.2017.06.039","article-title":"A macroporous heparin-releasing silk fibroin scaffold improves islet transplantation outcome by promoting islet revascularisation and survival","volume":"59","author":"Mao","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2021.05.039_bib0202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biomaterials.2016.02.043","article-title":"Improvement of islet engrafts by enhanced angiogenesis and microparticle-mediated oxygenation","volume":"89","author":"Montazeri","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.05.039_bib0203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.04.017","article-title":"Oxygen generating biomaterial improves the function and efficacy of beta cells within a macroencapsulation device","volume":"210","author":"Coronel","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.05.039_bib0204","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720971245","article-title":"Comparison of the effects of liraglutide on islet graft survival between local and systemic delivery","volume":"29","author":"Lee","year":"2020","journal-title":"Cell. Transplant."},{"key":"10.1016\/j.actbio.2021.05.039_bib0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.actbio.2018.06.006","article-title":"Polymeric microsphere-facilitated site-specific delivery of quercetin prevents senescence of pancreatic islets in vivo and improves transplantation outcomes in mouse model of diabetes","volume":"75","author":"Pathak","year":"2018","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0206","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s13346-018-0484-x","article-title":"Sustained exenatide delivery via intracapsular microspheres for improved survival and function of microencapsulated porcine islets","volume":"8","author":"Lew","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0207","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imr.12146","article-title":"Inflammatory triggers of acute rejection of organ allografts","volume":"258","author":"Mori","year":"2014","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0208","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/TP.0000000000001923","article-title":"Long-term functioning of allogeneic islets in subcutaneous tissue pretreated with a novel cyclic peptide without immunosuppressive medication","volume":"102","author":"Kuwabara","year":"2018","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.actbio.2021.05.039_bib0209","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2337\/db20-0248","article-title":"Localized immunosuppression with tannic acid encapsulation delays islet allograft and autoimmune-mediated rejection","volume":"69","author":"Barra","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.actbio.2021.05.039_bib0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2015.11.065","article-title":"Transforming growth factor-beta 1 delivery from microporous scaffolds decreases inflammation post-implant and enhances function of transplanted islets","volume":"80","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.05.039_bib0211","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.actbio.2019.11.021","article-title":"Biomaterial-mediated reprogramming of monocytes via microparticle phagocytosis for sustained modulation of macrophage phenotype","volume":"101","author":"Wofford","year":"2020","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0212","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1039\/C9BM01487J","article-title":"Clickable, acid labile immunosuppressive prodrugs for in vivo targeting","volume":"8","author":"Wang","year":"2020","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.039_bib0213","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1038\/s41598-019-40404-0","article-title":"Local release of rapamycin by microparticles delays islet rejection within the anterior chamber of the eye","volume":"9","author":"Fan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2021.05.039_bib0214","article-title":"Particulate-based single-dose local immunosuppressive regimen for inducing tolerogenic dendritic cells in xenogeneic islet transplantation","volume":"10","author":"Pathak","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2021.05.039_bib0215","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jconrel.2020.10.026","article-title":"Drug-integrating amphiphilic nanomaterial assemblies: 1. spatiotemporal control of cyclosporine delivery and activity using nanomicelles and nanofibrils","volume":"329","author":"Velluto","year":"2020","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0216","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/term.2464","article-title":"Local delivery of fingolimod from three-dimensional scaffolds impacts islet graft efficacy and microenvironment in a murine diabetic model","volume":"12","author":"Frei","year":"2018","journal-title":"J. Tissue Eng. Regen. Med."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0217","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.tp.0000250658.00925.c8","article-title":"Long-term survival of transplanted allogeneic cells engineered to express a T cell chemorepellent","volume":"83","author":"Papeta","year":"2007","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.actbio.2021.05.039_bib0218","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.4049\/jimmunol.177.11.8053","article-title":"CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis","volume":"177","author":"McCandless","year":"2006","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0219","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00125-009-1384-x","article-title":"Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2)","volume":"52","author":"Liu","year":"2009","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0220","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/ajt.13049","article-title":"Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression","volume":"15","author":"Chen","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0221","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/bies.20356","article-title":"The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation","volume":"28","author":"Pearl-Yafe","year":"2006","journal-title":"Bioessays"},{"issue":"8","key":"10.1016\/j.actbio.2021.05.039_bib0222","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41563-018-0099-0","article-title":"Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance","volume":"17","author":"Headen","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.actbio.2021.05.039_bib0223","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biomaterials.2018.11.015","article-title":"Localized immune tolerance from FasL-functionalized PLG scaffolds","volume":"192","author":"Skoumal","year":"2019","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.actbio.2021.05.039_bib0224","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ajt.15747","article-title":"Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege","volume":"20","author":"Woodward","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.039_bib0225","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4049\/jimmunol.163.3.1315","article-title":"Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells","volume":"163","author":"Inaba","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.039_bib0226","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/86336","article-title":"Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity","volume":"2","author":"Aoki","year":"2001","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.actbio.2021.05.039_bib0227","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1084\/jem.186.12.2045","article-title":"Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing","volume":"186","author":"Suda","year":"1997","journal-title":"J. Exp. Med."},{"issue":"35","key":"10.1016\/j.actbio.2021.05.039_bib0228","doi-asserted-by":"crossref","first-page":"eaba5573","DOI":"10.1126\/sciadv.aba5573","article-title":"Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival","volume":"6","author":"Coronel","year":"2020","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.actbio.2021.05.039_bib0229","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.4049\/jimmunol.2000055","article-title":"Localized immunomodulation with PD-L1 results in sustained survival and function of allogeneic islets without chronic immunosuppression","volume":"204","author":"Batra","year":"2020","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.039_bib0230","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biomaterials.2009.09.045","article-title":"Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation","volume":"31","author":"Su","year":"2010","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.actbio.2021.05.039_bib0231","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/db18-0202","article-title":"Humanized mouse model to study Type 1 Diabetes","volume":"67","author":"Luce","year":"2018","journal-title":"Diabetes"},{"issue":"276","key":"10.1016\/j.actbio.2021.05.039_bib0232","article-title":"Isogenic cellular systems model the impact of genetic risk variants in the pathogenesis of Type 1 Diabetes","volume":"8","author":"Wallet","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"96","key":"10.1016\/j.actbio.2021.05.039_bib0233","article-title":"Generation of thyroid follicular cells from pluripotent stem cells: potential for regenerative medicine","volume":"5","author":"Sewell","year":"2014","journal-title":"Front. Endocrinol."},{"issue":"10","key":"10.1016\/j.actbio.2021.05.039_bib0234","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/thy.2007.0183","article-title":"New insights into thyroid stem cells","volume":"17","author":"Lin","year":"2007","journal-title":"Thyroid"},{"issue":"70","key":"10.1016\/j.actbio.2021.05.039_bib0235","article-title":"New directions for the treatment of adrenal insufficiency","volume":"6","author":"Ruiz-Babot","year":"2015","journal-title":"Front. Endocrinol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121003494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121003494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:44:58Z","timestamp":1761673498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706121003494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":235,"alternative-id":["S1742706121003494"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2021.05.039","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2021.05.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}